drugset / Trial / NCT00027430

Androgen Replacement Therapy in Women With Hypopituitarism

NCT00027430 ↗

Completed 50 enrolled Massachusetts General Hospital
RandomizedParallel-groupTreatment

Summary

This is a study to determine whether testosterone replacement with TheraDerm can improve bone density, mood, sex drive, thinking, and distribution of body fat and muscle mass in women with hypopituitarism.

Timeline

Start
2001-09
Primary completion
—
Completion
2004-12

Outcome

Met primary endpoint

paper NT-proBNP levels decreased in the transdermal testosterone group compared with placebo over three months. PMID 22137497 ↗

paper The difference between groups remained significant after controlling for baseline age, systolic blood pressure, body mass index, and homeostasis model assessment of insulin resistance. PMID 22137497 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 300 ug Other

Indications